IIN IntriCon

IntriCon Announces Appointment of Sara Hill as Chief Human Resource Officer

IntriCon Announces Appointment of Sara Hill as Chief Human Resource Officer

ARDEN HILLS, Minn., April 30, 2020 (GLOBE NEWSWIRE) -- IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced Sara Hill has been appointed Chief Human Resource Officer. As a key member of IntriCon's executive leadership team, Ms. Hill will lead the company’s global human resources function, overseeing the efforts of organizational and leadership development, talent acquisition and talent management, succession planning and total rewards.

“We are delighted to welcome Sara to the IntriCon team. One of our top priorities this year is the implementation of an enhanced organizational structure that best aligns with our focus on driving a sustainable pipeline of growth opportunities,” said Mark Gorder, President and Chief Executive Officer at IntriCon. “Sara's demonstrated ability to build and grow high-performing teams made her an ideal fit to further our vision of delivering the most advanced products to meet the rising demand for smaller, more intelligent and better-connected medical devices.”

Ms. Hill brings over 20 years of strategic human resource and executive experience to IntriCon, rooted in a passion for developing strong partnerships with senior leaders and teams to build high-performing, dynamic organizations. Most recently she served as the Chief Human Resource Officer at Ceridian, where she led people engagement and talent strategies for an employee community of 5,000. Prior to Ceridian, she served as the Senior Vice President of Human Resources at US Bank.  

Ms. Hill holds a Bachelor of Arts degree in Communications from the University of Pennsylvania and a Master of Business Administration with Human Resources and Marketing concentrations from Vanderbilt University.

"I am excited to join this smart and dedicated group. IntriCon has long been at the forefront of medical device advancement and is well respected by customers and partners alike. It’s an honor to have the opportunity to contribute to the further momentum of this business," said Hill.

About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops and manufactures miniature interventional, implantable and body-worn medical devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market. For more information about IntriCon, visit .

Investor Relations Contact                                                              

Leigh Salvo                                   

(415) 937-5404    

EN
30/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IntriCon

 PRESS RELEASE

Intricon Announces Completion of Acquisition by an Affiliate of Altari...

Intricon Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners Investment by Altaris Supports Intricon’s Ability to Deliver Innovative Solutions and Service to its Customers ARDEN HILLS, Minn., May 24, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced the completion of its acquisition by funds affiliated with Altaris Capital Partners, LLC (toget...

 PRESS RELEASE

Intricon Reports Fourth Quarter and Full Year 2021 Results

Intricon Reports Fourth Quarter and Full Year 2021 Results ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021. Fourth Quarter Highlights: Revenue of $32.2 million compared to $30.3 million in the prior year period Diabetes revenue increased 2% compared to the prior year...

 PRESS RELEASE

Intricon Enters into Agreement to be Acquired by an Affiliate of Altar...

Intricon Enters into Agreement to be Acquired by an Affiliate of Altaris Capital Partners for $241 Million Intricon Shareholders to Receive $24.25 Per Share in Cash ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced that it has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, LLC (collectively with its affi...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: January 29, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: January 24, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch